Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Share-based Compensation (2016 - 2025)

Veracyte's Share-based Compensation history spans 12 years, with the latest figure at $10.9 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 13.21% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $43.6 million, up 20.28%, while the annual FY2025 figure was $43.6 million, 20.28% up from the prior year.
  • Share-based Compensation for Q4 2025 was $10.9 million at Veracyte, up from $10.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $11.0 million in Q2 2025 and bottomed at $3.9 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $7.9 million (2021), against an average of $8.1 million.
  • The largest annual shift saw Share-based Compensation surged 154.71% in 2021 before it dropped 7.44% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $6.7 million in 2021, then increased by 2.01% to $6.9 million in 2022, then rose by 9.39% to $7.5 million in 2023, then increased by 28.18% to $9.6 million in 2024, then rose by 13.21% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Share-based Compensation are $10.9 million (Q4 2025), $10.8 million (Q3 2025), and $11.0 million (Q2 2025).